Peripheral or spinal delivery of pVAX1-PENK alleviates CFA-induced pain for an extended period.
Peripheral or spinal delivery of pVAX1-PENK attenuates SNI-induced nocifensive behaviors in mice.
The analgesic effect of pVAX1-PENK is blocked by naloxone hydrochloride.